BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6456891)

  • 1. Serum and urine concentrations of cefoperazone in severe chronic renal failure.
    Bailey RR; Peddie B; Blake E
    Drugs; 1981; 22 Suppl 1():46-51. PubMed ID: 6456891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefoperazone: a review.
    Craig WA; Gerber AU
    Drugs; 1981; 22 Suppl 1():35-45. PubMed ID: 6456890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of a new cephalosporin, cefoperazone].
    Allaz AF; Dayer P; Fabre J; Rudhardt M; Balant L
    Schweiz Med Wochenschr; 1979 Dec; 109(50):1999-2005. PubMed ID: 538442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefoperazone in the treatment of severe or complicated infections.
    Bailey RR; Peddie B; Blake E; Bishop V; Reddy J
    Drugs; 1981; 22 Suppl 1():76-86. PubMed ID: 6456895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function.
    Greenfield RA; Gerber AU; Craig WA
    Rev Infect Dis; 1983; 5 Suppl 1():S127-36. PubMed ID: 6221382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cefoperazone in patients with neoplastic disease.
    Maksymiuk AW; LeBlanc BM; Brown NS; Ho DH; Bodey GP
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1037-41. PubMed ID: 6455966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetic study of a cephalosporin: cefoperazone in patients with a Kehr drain].
    Farquet C; Marti MC; Balant L; Cochet B; Rudhardt M; Fabre J; Rohner A
    Schweiz Med Wochenschr; 1982 Jan; 112(4):123-9. PubMed ID: 6461067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic.
    Neu HC
    Ther Drug Monit; 1981; 3(2):121-8. PubMed ID: 6455787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency.
    Bolton WK; Scheld WM; Spyker DA; Sande MA
    Antimicrob Agents Chemother; 1981 May; 19(5):821-5. PubMed ID: 6457558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cefoperazone--a new cephalosporin antibiotic with broader spectrum of activity].
    Jendroschek T; Belmega G; Lode H; Kemmerich B; Dzwillo G; Koeppe P; Wagner J
    Med Klin; 1981 Feb; 76(4):102-6, 70. PubMed ID: 6452567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of cefoperazone and cefotaxime.
    Lode H; Kemmerich B; Koeppe P; Belmega D; Jendroschek H
    Clin Ther; 1980; 3(Spec Issue):80-8. PubMed ID: 6248221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
    Iwata S; Sato Y; Iwasaki Y; Hayano S; Wakabayashi R; Kojima Y; Akita H; Sunakawa K; Oikawa T; Osano M
    Jpn J Antibiot; 1984 Oct; 37(10):1831-45. PubMed ID: 6094863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefadroxil in normal subjects and in patients with renal insufficiency.
    Humbert G; Leroy A; Fillastre JP; Godin M
    Chemotherapy; 1979; 25(4):189-95. PubMed ID: 456077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetic study of a cephalosporin, cefoperazone, in liver failure].
    Belaieff J; Cochet B; Allaz AF; Rudhardt M; Balant L; Fabre J
    Schweiz Med Wochenschr; 1981 Apr; 111(14):502-8. PubMed ID: 6453423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of moxalactam in adults].
    Humbert G; Leroy A; Fillastre JP
    Sem Hop; 1983 Jun; 59(26):1963-7. PubMed ID: 6310787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefoperazone therapy of complicated urinary tract infections: pharmacokinetics in renal transplant recipients.
    Goldstein EJ; Gombert ME; Sierra MF; Butt KM
    Chemotherapy; 1985; 31(1):6-12. PubMed ID: 3882354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cefoperazone--Possibility of safer treatment for infections in patients with chronic renal failure].
    Klinger M; Szewczyk Z; Kazimierczak K; Kramarz S
    Wiad Lek; 1990 Aug 1-15; 43(15-16):773-6. PubMed ID: 2275197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concentration of cefoperazone in various tissues of the urogenital system (author's transl)].
    Schalkhäuser K; Adam D
    Arzneimittelforschung; 1981; 31(10):1770-2. PubMed ID: 6459099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefoperazone pharmacokinetics in normal subjects and patients with cirrhosis.
    Boscia JA; Korzeniowski OM; Snepar R; Kobasa WD; Levison ME; Kaye D
    Antimicrob Agents Chemother; 1983 Mar; 23(3):385-9. PubMed ID: 6221691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.